搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Saccharomyces cerevisiae Mitochondrial organizing structure protein 1 (MOS1), partial CSB-YP839427SVG1
CSB-EP839427SVG1
CSB-BP839427SVG1
CSB-MP839427SVG1
CSB-EP839427SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia angusta Phosphoribosylaminoimidazole-succinocarboxamide synthase (ADE1) CSB-YP839428EVQ
CSB-EP839428EVQ
CSB-BP839428EVQ
CSB-MP839428EVQ
CSB-EP839428EVQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acetylxylan esterase A (axeA) CSB-YP839429DOW
CSB-EP839429DOW
CSB-BP839429DOW
CSB-MP839429DOW
CSB-EP839429DOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus kawachii Orotidine 5'-phosphate decarboxylase (pyrG) CSB-YP839430APP
CSB-EP839430APP
CSB-BP839430APP
CSB-MP839430APP
CSB-EP839430APP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe tRNA (guanine-N (7)-)-methyltransferase (trm8) CSB-YP839431SXV
CSB-EP839431SXV
CSB-BP839431SXV
CSB-MP839431SXV
CSB-EP839431SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Meiotically up-regulated gene 93 protein (mug93) CSB-YP839432SXV
CSB-EP839432SXV
CSB-BP839432SXV
CSB-MP839432SXV
CSB-EP839432SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable alpha-glucuronidase A (aguA), partial CSB-YP839433DOZ
CSB-EP839433DOZ
CSB-BP839433DOZ
CSB-MP839433DOZ
CSB-EP839433DOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Elongation factor 2 (cot-3), partial CSB-YP839434NHA
CSB-EP839434NHA
CSB-BP839434NHA
CSB-MP839434NHA
CSB-EP839434NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii Protease HtpX homolog 2 (htpX2), partial CSB-YP839435FPN1
CSB-EP839435FPN1
CSB-BP839435FPN1
CSB-MP839435FPN1
CSB-EP839435FPN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii Endonuclease NucS (nucS) CSB-YP839436FPN
CSB-EP839436FPN
CSB-BP839436FPN
CSB-MP839436FPN
CSB-EP839436FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii Cysteine--tRNA ligase (cysS) CSB-YP839437FPN
CSB-EP839437FPN
CSB-BP839437FPN
CSB-MP839437FPN
CSB-EP839437FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii Nucleoside-triphosphatase THEP1 (STK_21570) CSB-YP839438FPN
CSB-EP839438FPN
CSB-BP839438FPN
CSB-MP839438FPN
CSB-EP839438FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii D-tyrosyl-tRNA (Tyr) deacylase (dtdA) CSB-YP839439FPN
CSB-EP839439FPN
CSB-BP839439FPN
CSB-MP839439FPN
CSB-EP839439FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii 30S ribosomal protein S4P (rps4p) CSB-YP839440FPN
CSB-EP839440FPN
CSB-BP839440FPN
CSB-MP839440FPN
CSB-EP839440FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii UPF0103 protein STK_20620 (STK_20620) CSB-YP839441FPN
CSB-EP839441FPN
CSB-BP839441FPN
CSB-MP839441FPN
CSB-EP839441FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii 7-cyano-7-deazaguanine synthase 1 (queC1) CSB-YP839442FPN
CSB-EP839442FPN
CSB-BP839442FPN
CSB-MP839442FPN
CSB-EP839442FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii Putative esterase STK_17900 (STK_17900) CSB-YP839443FPN
CSB-EP839443FPN
CSB-BP839443FPN
CSB-MP839443FPN
CSB-EP839443FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii Aspartate carbamoyltransferase regulatory chain (pyrI) CSB-YP839444FPN
CSB-EP839444FPN
CSB-BP839444FPN
CSB-MP839444FPN
CSB-EP839444FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase (hisA) CSB-YP839445FPN
CSB-EP839445FPN
CSB-BP839445FPN
CSB-MP839445FPN
CSB-EP839445FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus tokodaii Glutamine amidotransferase subunit pdxT (pdxT) CSB-YP839446FPN
CSB-EP839446FPN
CSB-BP839446FPN
CSB-MP839446FPN
CSB-EP839446FPN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>